Early central line-associated blood stream infections in children with cancer pose a risk for premature catheter removal

Acta Paediatr. 2019 Feb;108(2):361-366. doi: 10.1111/apa.14432. Epub 2018 Jun 27.

Abstract

Aim: This study examined the clinical characteristics of central line-associated blood stream infections occurring within 30 days after insertion versus later infections in paediatric cancer patients and the subsequent risk for premature catheter removal.

Methods: This was a retrospective study of children aged 0-18 years who were diagnosed with cancer from 2013 to 2014 at the Astrid Lindgren Children Hospital, Sweden. Clinical and microbiology data for each patient were collected for 365 days after the central venous catheter (CVC) was inserted.

Results: During the study period, 154 children received a CVC. The overall incidence of central line associated blood stream infections was 2.0 per 1000 catheter days. A total of 108 infectious episodes were identified in 44/154 (29%) patients. Of those, 15/44 children (29%) had an early infection within 30 days and alpha-haemolytic Streptococci and coagulase-negative Staphylococci dominated. Children with early infections were more likely to have a haematological malignancy and to need premature removal of the CVC due to repeated infections.

Conclusion: We observed a high prevalence of early CVC associated blood stream infection mainly in patients with haematological malignancies. Our study highlights the importance of preventive measures in reducing infections in paediatric cancer patients.

Keywords: Blood stream infections; Central venous catheters; Haematological malignancies; Paediatric cancer patients; Preventing infections.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antineoplastic Agents / therapeutic use
  • Bacteremia / etiology*
  • Catheterization, Central Venous / adverse effects*
  • Child
  • Child, Preschool
  • Device Removal / statistics & numerical data
  • Humans
  • Infant
  • Neoplasms / drug therapy
  • Retrospective Studies

Substances

  • Antineoplastic Agents